Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission

Show other versions (2)

Bibliographic Details
Main Authors:	Alvarez-Erviti, L, Seow, Y, Schapira, A, Gardiner, C, Sargent, I, Wood, M, Cooper, J
Format:	Journal article
Published:	2011

Similar Items

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.
by: Alvarez-Erviti, L, et al.
Published: (2011)

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
by: Alvarez-Erviti, L, et al.
Published: (2011)

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
by: Lydia Alvarez-Erviti, et al.
Published: (2011-06-01)

Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line.
by: Alvarez-Erviti, L, et al.
Published: (2011)

Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
by: Alvarez-Erviti, L, et al.
Published: (2011)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
by: Danzer Karin M, et al.
Published: (2012-08-01)

Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson’s Disease
by: Denisse Sepúlveda, et al.
Published: (2022-02-01)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
by: Alba Navarro-Romero, et al.
Published: (2022-10-01)

Exosome-mediated delivery of siRNA in vitro and in vivo.
by: El-Andaloussi, S, et al.
Published: (2012)

Intercellular transmission of alpha-synuclein
by: Shenjie Wu, et al.
Published: (2024-09-01)

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
by: Mali Cosden, et al.
Published: (2021-11-01)

Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models
by: Alice Drobny, et al.
Published: (2023-06-01)

Intrastriatal Administration of Exosome-Associated Pathological Alpha-Synuclein Is Not Sufficient by Itself to Cause Pathology Transmission
by: Mantia Karampetsou, et al.
Published: (2020-04-01)

Lysosomal-endolysomal dysfunction and neurodegenerative diseases
by: Matthew E. Gegg, et al.
Published: (2022-10-01)

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
by: Qiao Liyan, et al.
Published: (2008-11-01)

Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
by: Yaping Chu, et al.
Published: (2009-09-01)

Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein.
by: Senior, S, et al.
Published: (2008)

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
by: Maria Izco, et al.
Published: (2022-05-01)

Alpha-synuclein dysfunction in Lewy body diseases.
by: Tofaris, G, et al.
Published: (2005)

Alpha-synuclein in mitochondrial dysfunction: opportunities or obstacles
by: Shermali Gunawardena
Published: (2025-01-01)

Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures
by: André M. Miranda, et al.
Published: (2018-01-01)

Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway.
by: Tofaris, G, et al.
Published: (2011)

Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity.
by: Meigen Yu, et al.
Published: (2023-05-01)

Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
by: Qilin Tang, et al.
Published: (2021-09-01)

The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
by: Michael P. Nelson, et al.
Published: (2018-02-01)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
by: Inês C. Brás, et al.
Published: (2021-02-01)

Delivery of siRNA to the brain by systemic injection of targeted exosomes
by: Alvarez-Erviti, L, et al.
Published: (2011)

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
by: Ying Xue Xie, et al.
Published: (2022-08-01)

Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
by: A. R. Esteves, et al.
Published: (2011-01-01)

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
by: Veronica Ghiglieri, et al.
Published: (2018-05-01)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
by: Alessia Indrieri, et al.
Published: (2020-10-01)

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
by: Alvarez-Erviti, L, et al.
Published: (2011)

Thioredoxin-1 decreases alpha-synuclein induced by MPTP through promoting autophagy-lysosome pathway
by: Rou Gu, et al.
Published: (2024-02-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord
by: Maria Izco, et al.
Published: (2023-04-01)

Internalization, axonal transport and release of fibrillar forms of alpha-synuclein
by: Gregor Bieri, et al.
Published: (2018-01-01)

Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
by: Georgia Dermentzaki, et al.
Published: (2013-01-01)

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
by: Emily M. Rocha, et al.
Published: (2018-01-01)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
by: Yanina Dening, et al.
Published: (2022-12-01)

Ceramide-Induced Lysosomal Biogenesis and Exocytosis in Early-Onset Preeclampsia Promotes Exosomal Release of SMPD1 Causing Endothelial Dysfunction
by: Leonardo Ermini, et al.
Published: (2021-05-01)